Talks on resilience, future technologies and digital evidence at symposium
The Central Coast Business Symposium in Arroyo Grande on April 2 drew several hundred business and community leaders to learn more about how to protect their business from hackers from within and without, how to build more resilient organizations and how to prepare for technological change. The symposium is organized by law firm Andre, Morris Read More →
Ventura County could seek drones without FAA
Ventura County would consider going ahead with opening a drone test site even if it is not one of the six applicants out of 50 nationwide that are selected by the Federal Aviation Administration to lead the way in integrating the unmanned aerial vehicles into the national airspace. That was the word from panelists at Read More →
Limoneira predicts bumper lemon and avocado crop
Santa Paula-based Limoneira Co. told shareholders on March 26 that it expects a 25 percent jump in lemon sales and a record avocado crop in 2013. CEO Harold Edwards said avocados could hit 18 million pounds this year — up 50 percent from 2012. But because of strong production and higher volumes, avocado prices will Read More →
Markwith to retire from top post at Sierra Vista
After eight years at the helm of San Luis Obispo’s Sierra Vista Regional Medical Center, Candace “Candy” Markwith will retire in September. Markwith, who has been head of the 164-bed hospital since March 2005, announced her upcoming retirement on March 25. With 772 employees, Sierra Vista is the largest employer in the city of San Read More →
FCAL shareholders vote in favor of merger with PacWest
Shareholders in First California Financial Group voted overwhelmingly in favor of merging the bank into rival PacWest Bancorp at a March 20 meeting. Investors in the Westlake Village bank cast 23.4 million votes in favor of the $233 million deal, with 212,252 shares voting against the proposal and 5,865 abstaining. The deal still requires regulatory Read More →
Amgen shares jump on good news from melanoma drug study
[wikichart align=”right” ticker=”NASDAQ:AMGN” showannotations=”true” livequote=”true” startdate=”20-09-2012″ enddate=”20-03-2013″ width=”300″ height=”245″] Shares of Thousand Oaks-based Amgen rose in light trading on March 20 after the company announced favorable results from a drug that treats advanced melanoma. The drug, dubbed T-VEC, uses a virus to infiltrate tumors and shrink them. It achieved positive results in a large number Read More →
